Charles River Laboratories | Des Atouts



Assets Changement Date
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.21B 151.37M 2024-12
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Cardinal Health USD 47B 3.94B 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Cigna USD 155.88B 1.76B 2024-12
CVS Health USD 253.22B 788M 2024-12
Danaher USD 77.54B 3.07B 2024-12
Dentsply International USD 5.75B 873M 2024-12
Elevance Health USD 116.67B 140M 2024-12
Galapagos EUR 4.14B 36.48M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Humana USD 46.48B 3.53B 2024-12
Illumina USD 6.3B 289M 2024-12
Incyte USD 5.44B 431.89M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Laboratory Of America USD 18.38B 233.5M 2024-12
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 71.08B 1.35B 2024-12
Merck EUR 50.14B 267M 2024-09
Mettler Toledo International USD 3.24B 79.83M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Quest Diagnostics USD 16.15B 58M 2024-12
Revvity USD 12.39B 377.26M 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12
UnitedHealth USD 298.28B 1.03B 2024-12
Walgreens Boots Alliance USD 78.54B 2.5B 2024-11
Waters USD 4.55B 42.18M 2024-12
West Pharmaceutical Services USD 3.64B 31.7M 2024-12



Charles River Laboratories Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.